Modern management of ocular surface squamous neoplasia

References

• Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br. J. Cancer 74(10), 1511–1513 (1996).
   PubMedGoogle Scholar
• Kiire CA, Srinivasan S, Karp CL. Ocular surface squamous neoplasia. Int. Ophthalmol. Clin. 50(3), 35–46 (2010).
   PubMedGoogle Scholar
• Gaasterland DE, Rodrigues MM, Moshell AN. Ocular involvement in xeroderma pigmentosum. Ophthalmology 89(8), 980–986 (1982).
   PubMed Web of Science ®Google Scholar
• Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br. J. Ophthalmol. 80(6), 503–508 (1996).
   PubMed Web of Science ®Google Scholar
• Karp CL, Scott IU, Chang TS, Pflugfelder SC. Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency virus infection? Arch. Ophthalmol. 114(3), 257–261 (1996).
   PubMed Web of Science ®Google Scholar
• Newton R, Ferlay J, Reeves G, Beral V, Parkin DM. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 347(9013), 1450–1451 (1996).
   PubMed Web of Science ®Google Scholar
• Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345(8951), 695–696 (1995).
   PubMedGoogle Scholar
• Pe’er J, Frucht-Pery J. Ocular surface squamous neoplasia. In: Clinical Ophthalmic Oncology. Singh AD, Pe’er J, Murphree AL (Eds). Elsevier, PA, USA, 136 (2007).
   Google Scholar
• Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 92(6), 728–733 (1985).
   PubMed Web of Science ®Google Scholar
• Nolan GR, Hirst LW, Wright RG, Bancroft BJ. Application of impression cytology to the diagnosis of conjunctival neoplasms. Diagn. Cytopathol. 11(3), 246–249 (1994).
   PubMedGoogle Scholar
• Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101(2), 360–364 (1994).
   PubMed Web of Science ®Google Scholar
• Gelender H, Forster RK. Papanicolaou cytology in the diagnosis and management of external ocular tumors. Arch. Ophthalmol. 98(5), 909–912 (1980).
   PubMedGoogle Scholar
• Xu Y, Zhou Z, Xu Y et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye (Lond.) 26(6), 781–787 (2012).
   PubMed Web of Science ®Google Scholar
• Hassani RT, Brasnu E, Amar N et al. Contribution of in vivo confocal microscopy to diagnosis of invasive ocular surface squamous neoplasia: a case report. J. Fr. Ophtalmol. 33(3), 163–168 (2010).
   PubMed Web of Science ®Google Scholar
• Duchateau N, Hugol D, D’Hermies F et al. Contribution of in vivo confocal microscopy to limbal tumor evaluation. J. Fr. Ophtalmol. 28(8), 810–816 (2005).
   PubMed Web of Science ®Google Scholar
• Kieval JZ, Karp CL, Abou Shousha M et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology 119(3), 481–486 (2012).
   PubMed Web of Science ®Google Scholar
• Chevaliez S, Pawlotsky JM. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. 59(12), 1222–1241 (2007).
   PubMed Web of Science ®Google Scholar
• Chakalova G, Ganchev G. Local administration of interferon-α in cases of cervical intraepithelial neoplasia associated with human papillomavirus infection. J. BUON 9(4), 399–402 (2004).
   PubMedGoogle Scholar
• Edwards L, Berman B, Rapini RP et al. Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. Arch. Dermatol. 128(11), 1486–1489 (1992).
   PubMed Web of Science ®Google Scholar
• Boehm JS, Hahn WC. Immortalized cells as experimental models to study cancer. Cytotechnology 45(1–2), 47–59 (2004).
   PubMedGoogle Scholar
• Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 106(1), 91–97 (1999).
   PubMed Web of Science ®Google Scholar
• Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon α-2b. Ophthalmology 108(6), 1093–1098 (2001).
   PubMed Web of Science ®Google Scholar
• Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon α-2b. Cornea 21(1), 6–11 (2002).
   PubMed Web of Science ®Google Scholar
• Sepulveda R, Pe’er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br. J. Ophthalmol. 94(5), 532–535 (2010).
   PubMedGoogle Scholar
• Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin. Ophthalmol. 2(3), 503–515 (2008).
   PubMedGoogle Scholar
• Cornell RC, Greenway HT, Tucker SB et al. Intralesional interferon therapy for basal cell carcinoma. J. Am. Acad. Dermatol. 23(4 Pt 1), 694–700 (1990).
   PubMed Web of Science ®Google Scholar
• Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon α 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br. J. Ophthalmol. 94(5), 551–554 (2010).
   PubMed Web of Science ®Google Scholar
• Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 115(8), 1297.e1–1302.e1 (2008).
   Google Scholar
• Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE. Giant ocular surface squamous neoplasia managed with interferon α-2b as immunotherapy or immunoreduction. Ophthalmology 119(5), 938–944 (2012).
   PubMed Web of Science ®Google Scholar
• Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon a2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology 117(12), 2241–2246 (2010).
   PubMed Web of Science ®Google Scholar
• Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer. Drugs 1(1), 5–13 (1990).
   PubMedGoogle Scholar
• Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs 66(3), 321–340 (2006).
   PubMed Web of Science ®Google Scholar
• Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblasts. Ophthalmology 99(9), 1471–1476 (1992).
   PubMed Web of Science ®Google Scholar
• Derick RJ, Pasquale L, Quigley HA, Jampel H. Potential toxicity of mitomycin C. Arch. Ophthalmol. 109(12), 1635 (1991).
   PubMed Web of Science ®Google Scholar
• Prabhasawat P, Tseng SC. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch. Ophthalmol. 115(11), 1360–1367 (1997).
   PubMedGoogle Scholar
• Frucht-Pery J, Sugar J, Baum J et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 104(12), 2085–2093 (1997).
   PubMed Web of Science ®Google Scholar
• Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am. J. Ophthalmol. 124(3), 303–311 (1997).
   PubMed Web of Science ®Google Scholar
• Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with mitomycin C. Br. J. Ophthalmol. 94(5), 555–558 (2010).
   PubMed Web of Science ®Google Scholar
• Georgopoulos M, Vass C, Vatanparast Z. Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. Curr. Eye Res. 25(4), 221–225 (2002).
   PubMed Web of Science ®Google Scholar
• Quebbeman EJ, Hoffman NE, Ausman RK, Hamid AA. Stability of mitomycin admixtures. Am. J. Hosp. Pharm. 42(8), 1750–1754 (1985).
   PubMedGoogle Scholar
• Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br. J. Ophthalmol. 90(7), 819–822 (2006).
   PubMed Web of Science ®Google Scholar
• Russell HC, Chadha V, Lockington D, Kemp EG. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br. J. Ophthalmol. 94(10), 1316–1321 (2010).
   PubMed Web of Science ®Google Scholar
• Billing K, Karagiannis A, Selva D. Punctal–canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am. J. Ophthalmol. 136(4), 746–747 (2003).
   PubMed Web of Science ®Google Scholar
• Kubota T. 5-fluorouracil and dihydropyrimidine dehydrogenase. Int. J. Clin. Oncol. 8(3), 127–131 (2003).
   PubMedGoogle Scholar
• Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA. 5-fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 107(12), 2190–2195 (2000).
   PubMed Web of Science ®Google Scholar
• Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br. J. Ophthalmol. 84(3), 268–272 (2000).
   PubMed Web of Science ®Google Scholar
• Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin. Ophthalmol. 21(3), 161–169 (2006).
   PubMedGoogle Scholar
• de Keizer RJ, de Wolff-Rouendaal D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc. Ophthalmol. 64(1), 31–42 (1986).
   PubMed Web of Science ®Google Scholar
• Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil. Arch. Ophthalmol. 115(12), 1600–1601 (1997).
   PubMedGoogle Scholar
• Yamamoto N, Ohmura T, Suzuki H, Shirasawa H. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology 109(2), 249–252 (2002).
   PubMedGoogle Scholar
• Di Pascuale MA, Espana EM, Tseng SC. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea 23(1), 89–92 (2004).
   PubMedGoogle Scholar
• Huerva V, Mateo AJ, Mangues I, Jurjo C. Short-term mitomycin C followed by long-term interferon α2β for conjunctiva–cornea intraepithelial neoplasia. Cornea 25(10), 1220–1223 (2006).
   PubMedGoogle Scholar
• Morrow CS, Cowan KH. Drug resistance and its clinical circumvention. In: Cancer Medicine (3rd Edition). Holland JF, Frei E III, Bast RC (Eds). Lea & Febiger, PA, USA, Vol. 1, sect. XV (1993).
   Google Scholar
• Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br. J. Ophthalmol. 82(5), 476–479 (1998).
   PubMedGoogle Scholar
• Frei E III, Antman KH. Combination chemotherapy, dose, and schedule. In: Cancer Medicine (3rd Edition). Holland JF, Frei E III, Bast RC (Eds). Lea & Febiger, PA, USA, Vol. 1, sect. XV (1993).
   Google Scholar
• Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. Am. J. Ophthalmol. 138(2), 183–189 (2004).
   PubMed Web of Science ®Google Scholar
• Pizzarello LD, Jakobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Ocular and Adnexal Tumors. Jakobiec FA (Ed.). Aesculapius, AL, USA, 553–571 (1978).
   Google Scholar
• Cerezo L, Otero J, Aragón G et al. Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90. Radiother. Oncol. 17(3), 191–197 (1990).
   PubMed Web of Science ®Google Scholar
• Ferry AP, Meltzer MA, Taub RN. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva. Trans. Am. Ophthalmol. Soc. 74, 154–171 (1976).
   PubMedGoogle Scholar
• Danopoulos ED, Danopoulou IE, Liarikos SB, Merkuris KM. Effects of urea treatment in malignancies of the conjunctiva and cornea. Ophthalmologica 178, 198–203 (1979).
   PubMedGoogle Scholar
• Herbort CP, Zografos L, Zwingli M, Schoeneich M. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium. Graefes Arch. Clin. Exp. Ophthalmol. 226(1), 22–26 (1988).
   PubMed Web of Science ®Google Scholar
• Krilis M, Tsang H, Coroneo M. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Ophthalmology 119(10), 1969–1973 (2012).
   PubMed Web of Science ®Google Scholar
• Paul S, Stone DU. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia. J. Ocul. Pharmacol. Ther. 28(6), 647–649 (2012).
   PubMed Web of Science ®Google Scholar
• Spadea L, Petrucci R, Balestrazzi E. excimer laser phototherapeutic keratectomy for recurrent intraepithelial corneoconjunctival carcinoma. J. Cataract Refract. Surg. 28(11), 2062–2064 (2002).
   PubMedGoogle Scholar
• Hodson K, Karp C. Removal of ocular surface squamous neoplasia with cryotherapy and amniotic membrane transplantation. Techniques in Ophthalmology. 9, 1–4 (2011).
   Google Scholar
• Nelson KD, McSoley JJ. Clinical findings and management of conjunctival intraepithelial neoplasia. Optometry 82(1), 15–21 (2011).
   PubMedGoogle Scholar
• Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv. Ophthalmol. 39(6), 429–450 (1995).
   PubMed Web of Science ®Google Scholar
• Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104(3), 485–492 (1997).
   PubMed Web of Science ®Google Scholar
• Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul. Surf. 1(2), 66–73 (2003).
   PubMedGoogle Scholar
• Wilkes TD, Fraunfelder FT. Principles of cryosurgery. Ophthalmic Surg. 10(8), 21–30 (1979).
   PubMedGoogle Scholar
• Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24(4), 369–377 (2005).
   PubMed Web of Science ®Google Scholar
• Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br. J. Ophthalmol. 86(6), 640–645 (2002).
   PubMed Web of Science ®Google Scholar
• Zaki AA, Farid SF. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Cornea 28(9), 986–988 (2009).
   PubMedGoogle Scholar
• Mohammadpour M. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva. Cornea 31(4), 465 (2012).
   PubMedGoogle Scholar
• Galor A, Karp CL, Oellers P et al. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology 119(10), 1974–1981 (2012).
   PubMed Web of Science ®Google Scholar
• Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93(2), 176–183 (1986).
   PubMed Web of Science ®Google Scholar
• Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Aust. N. Z. J. Ophthalmol. 25(4), 269–276 (1997).
   PubMedGoogle Scholar
• Buus DR, Tse DT, Folberg R, Buuns DR. Microscopically controlled excision of conjunctival squamous cell carcinoma. Am. J. Ophthalmol. 117(1), 97–102 (1994).
   PubMed Web of Science ®Google Scholar